Animal Health Partnering Terms and Agreements 2017 to 2026
Provides comprehensive understanding and unprecedented access to the animal health agreements entered into by the world's leading biopharma companies.
Benchmark Partnering Strategies Across the Global Animal Health Industry
The Animal Health Partnerships 2017–2026 report provides a comprehensive analysis of partnering agreements across the global animal health sector. Designed for business development, licensing, and strategy professionals, the report delivers detailed insight into how companies structure partnerships to develop, commercialize, and distribute veterinary medicines, vaccines, diagnostics, and animal health technologies.
Fully revised and updated, the report analyzes over 280 animal health agreements announced since 2017, providing a clear view of how companies collaborate across research, development, and commercialization. These partnerships often combine multiple components—beginning with collaborative R&D and progressing through licensing, manufacturing, or commercialization agreements.
Each deal record includes financial information where available and links to detailed online deal records. Where agreements have been publicly filed, the report also provides direct access to contract documents submitted to regulators, enabling users to examine the detailed terms negotiated between partners.
By combining detailed deal data, financial benchmarking, and access to real contract documents, the report provides valuable intelligence for evaluating potential partners, structuring collaboration agreements, and negotiating stronger deals within the animal health industry.
Key Benefits
✔ Save Significant Research Time
Access a consolidated resource covering hundreds of animal health partnerships rather than searching multiple databases, press releases, and regulatory filings.
✔ Benchmark Animal Health Deal Structures
Understand how companies structure veterinary and animal health partnerships, including collaborative R&D agreements, licensing arrangements, and commercialization partnerships.
✔ Analyze Financial Terms with Confidence
Review financial deal terms—including headline values, upfront payments, milestone payments, and royalties—to benchmark the value of comparable partnerships.
✔ Access Real Contract Documents
Where available, explore actual partnership agreements filed with the SEC, providing insight into detailed contractual provisions that are often not disclosed publicly.
✔ Identify the Most Active Animal Health Dealmakers
Discover which companies are leading partnering activity across the animal health sector and analyze their collaboration strategies.
✔ Track Industry Partnering Trends
Analyze partnership activity since 2017 across technologies, therapy areas, and development stages to understand how the animal health industry is evolving.
What’s Included in the Report
-
Analysis of animal health partnering trends since 2017
-
Overview of animal health deal structures and financial models
-
Review of the leading animal health partnerships by deal value
-
Profiles of the top 25 most active animal health dealmakers
-
Detailed analysis of deals organized by technology type, therapy area, and development stage
-
A comprehensive directory of animal health partnerships organized by company A–Z
-
Links to online deal records and contract documents where available
Due Diligence Insights from Real Agreements
By reviewing actual partnership contracts, the report enables users to evaluate key deal provisions such as:
-
Licensing and development rights
-
Financial payment structures and milestone triggers
-
Intellectual property ownership and licensing scope
-
Development and commercialization responsibilities
-
Exclusivity provisions and territorial rights
-
Contract duration and termination clauses
Contract documents provide valuable insight into the detailed terms negotiated between companies—information rarely disclosed in press releases or traditional deal databases.
Why This Report Matters
Strategic partnerships are essential to innovation in the animal health industry, allowing companies to combine technologies, share development risk, and expand global commercialization capabilities.
By providing comprehensive deal data, financial benchmarking, and access to real contract agreements, this report delivers the intelligence needed to evaluate partnership opportunities, structure stronger collaboration agreements, and negotiate more effectively in the animal health sector.
Key Benefits
✔ Save Significant Research Time
Access a consolidated resource covering hundreds of animal health partnerships rather than searching multiple databases, press releases, and regulatory filings.
✔ Benchmark Animal Health Deal Structures
Understand how companies structure veterinary and animal health partnerships, including collaborative R&D agreements, licensing arrangements, and commercialization partnerships.
✔ Analyze Financial Terms with Confidence
Review financial deal terms—including headline values, upfront payments, milestone payments, and royalties—to benchmark the value of comparable partnerships.
✔ Access Real Contract Documents
Where available, explore actual partnership agreements filed with the SEC, providing insight into detailed contractual provisions that are often not disclosed publicly.
✔ Identify the Most Active Animal Health Dealmakers
Discover which companies are leading partnering activity across the animal health sector and analyze their collaboration strategies.
✔ Track Industry Partnering Trends
Analyze partnership activity since 2017 across technologies, therapy areas, and development stages to understand how the animal health industry is evolving.
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in animal health dealmaking
2.1. Introduction
2.2. Animal health partnering over the years
2.3. Most active animal health dealmakers
2.4. Animal health partnering by deal type
2.5. Animal health partnering by therapy area
2.6. Animal health partnering by technology type
2.7. Deal terms for animal health partnering
2.7.1 Animal health partnering headline values
2.7.2 Animal health deal upfront payments
2.7.3 Animal health deal milestone payments
2.7.4 Animal health royalty rates
Chapter 3 – Leading animal health deals
3.1. Introduction
3.2. Top animal health deals by value
Chapter 4 – Most active animal health dealmakers
4.1. Introduction
4.2. Most active animal health dealmakers
4.3. Most active animal health partnering company profiles
Chapter 5 – Animal health contracts dealmaking directory
5.1. Introduction
5.2. Animal health contracts dealmaking directory
Chapter 6 – Animal health dealmaking by technology type
Appendices
Appendix 1 – Animal health deals by company A-Z
Appendix 2 – Animal health deals by stage of development
Appendix 3 – Animal health deals by deal type
Appendix 4 – Animal health deals by therapy area
Appendix 5 – Deal type definitions
Appendix 6 – Further reading
About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering
Table of figures
Figure 1: Animal health partnering since 2017
Figure 2: Active animal health dealmaking activity since 2017
Figure 3: Animal health partnering by deal type since 2017
Figure 4: Animal health partnering by disease type since 2017
Figure 5: Animal health partnering by technology type since 2017
Figure 6: Animal health deals with a headline value
Figure 7: Animal health deals with an upfront value
Figure 8: Animal health deals with a milestone value
Figure 9: Animal health deals with a royalty rate value
Figure 10: Top animal health deals by value since 2017
Figure 11: Most active animal health dealmakers since 2017
Pricing options
- $3,995: single-user
- $5,995: multi-user
- $7,995: corporate/enterprise license
A full explanation of license type definitions can be found here.
Our guarantee
Price promise
We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.
Latest report
If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.
Serious Security
We take your data and security seriously. See our privacy policy for details of how we manage your data.
Sales Support
If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.
- Total Trust
Current Partnering is part of Biopharma Research Ltd based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.
About Current Partnering
A definitive, evidence-based approach to dealmaking intelligence
Current Partnering is the industry-leading provider of pharmaceutical and biotech dealmaking intelligence, delivering a clear, structured, and evidence-based view of how partnerships are designed, negotiated, and executed in practice.
Our reports combine comprehensive deal coverage, structured data analysis, and contract-level insight, enabling a deeper understanding of how financial terms, rights, and responsibilities are defined across real-world transactions.
All reports are updated every six months, ensuring users have access to the latest deal activity, trends, and market developments.
Our methodology
Built on a continuously updated proprietary database
All analysis is underpinned by Current Agreements, our proprietary deals and alliances database which is updated daily by our analysts as new transactions are announced globally.
Deal records are continuously reviewed and enriched as additional information becomes available, ensuring accuracy, completeness, and relevance.
Comprehensive and verifiable data sourcing
Deal data is sourced from publicly available industry disclosures, including:
- Company press releases and announcements
- SEC filings and equivalent regulatory disclosures
- Company and investor presentations
- Conference materials and company websites
All sources are captured and referenced, enabling full transparency and user verification.
Broad coverage across deal types and structures
Current Partnering provides comprehensive coverage across a wide range of deal types, including but not limited to:
- Licensing and co-development
- Research and collaborative R&D
- Manufacturing, supply, and distribution
- Commercialisation and co-promotion
- Equity investments, joint ventures, and asset transactions
- Options, royalties, and financing agreements
This breadth ensures a complete view of how partnerships are structured across the life sciences sector.
Structured, standardised analysis
Every deal is analysed using a consistent framework, capturing (where disclosed):
- Financial terms — including upfront payments, milestones, and royalties
- Rights allocation — development, manufacturing, and commercialization responsibilities
- Deal structure — exclusivity, territorial scope, and agreement type
- Contractual provisions — clauses defining risk, control, and value-sharing
Each deal record is fully categorised, including data fields such as:
- Therapy area and technology type
- Stage of development
- Asset type and deal components
- Geographic scope and exclusivity
- Source documentation, including press releases and SEC filings
Financial normalisation for comparability
All financial values are standardised to USD using the exchange rate at the time of deal announcement, enabling consistent comparison of deal terms across geographies.
Contract-level insight
Where available, reports include direct access to underlying agreement documents, providing visibility into how deals are constructed in practice.
This enables users to understand:
- How financial mechanisms are defined and triggered
- How responsibilities are operationalised between parties
- How flexibility, risk, and control are allocated within agreements
Designed for real-world application
Current Partnering reports are built to support business-critical decision-making across the life sciences ecosystem, including:
- Pharmaceutical and biotech companies — benchmarking deals, structuring transactions, and supporting licensing strategy
- Investment firms and venture capital — assessing deal benchmarks, valuation expectations, and partner behaviour
- Advisory, legal, and consulting firms — supporting client engagements with real-world precedent and contract-level insight
Common use cases include:
- Benchmarking comparable transactions
- Supporting valuation and deal structuring
- Preparing for negotiations
- Evaluating potential partners
- Informing internal strategy with real-world evidence
A trusted industry reference
With a long track record in the sector, Current Partnering is relied upon by leading pharmaceutical companies, emerging biotechs, investors, and advisory firms as a trusted source of dealmaking intelligence.
By combining proprietary data, rigorous methodology, and contract-level insight, our reports provide a reliable and authoritative foundation for understanding how deals are structured, negotiated, and valued.
